FDA Approves IBRANCE (palbociclib) for the Treatment of Men with HR+, HER2- Metastatic Breast Cancer Read more
Roivant and Sinovant Launch Cytovant Sciences in Partnership with Medigene to Develop Cellular Therapies in Asia Read more
Editas and BlueRock Enter Strategic Research Collaboration and Cross-Licensing Agreement to Combine Genome Editing and Cell Therapy Platforms Read more
Dyne Therapeutics Launches with $50 Million Series A to Develop Targeted Therapies for Muscle Diseases Read more
FDA Clears the IND for UCARTCS1, the First Allogeneic CAR-T to Treat Multiple Myeloma Patients Read more